Skip to main content
OpenTrials

Clinical trial condition

Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations

Explore clinical trials studying Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations trial results

Completed

Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML

NCT03250338

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations
  • City of Hope National Medical Center Sacramento, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of Florida Gainesville, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View all 62 locations
View Trial Details

Related conditions